Synlogic (SYBX)
(Delayed Data from NSDQ)
$1.45 USD
-0.02 (-1.36%)
Updated Jul 11, 2024 04:00 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Brokerage Reports
Synlogic, Inc. [SYBX]
Reports for Purchase
Showing records 101 - 111 ( 111 total )
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
AACR Presentations Highlight I/O Pipeline; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
First Patient Dosed in SYNB1020 Phase 1/2a Hyperammonemia Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
4Q and FY2017 Financial Results Reported; Considerable Operational Runway; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Strong Cash Position and Pipeline Progress Makes for an Attractive Setup
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Shares Remain Attractively Priced as Lead Pipeline Programs Progress
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at OUTPERFORM; You Are What You Eat: Engineered Bugs to the Rescue
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D